Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
October 02, 2026 0.0141
October 01, 2026 0.0141
September 30, 2026 0.0141
September 29, 2026 0.0141
September 28, 2026 0.0141
September 25, 2026 0.0141
September 24, 2026 0.0141
September 23, 2026 0.0141
September 22, 2026 0.0141
September 21, 2026 0.0141
September 18, 2026 0.0141
September 17, 2026 0.0141
September 16, 2026 0.0141
September 15, 2026 0.0141
September 14, 2026 0.0141
September 11, 2026 0.0141
September 10, 2026 0.0141
September 09, 2026 0.0141
September 08, 2026 0.0141
September 04, 2026 0.0141
September 03, 2026 0.0141
September 02, 2026 0.0141
September 01, 2026 0.0141
August 31, 2026 0.0141
August 28, 2026 0.0141
Date Value
August 27, 2026 0.0141
August 26, 2026 0.0141
August 25, 2026 0.0141
August 24, 2026 0.0141
August 21, 2026 0.0141
August 20, 2026 0.0141
August 19, 2026 0.0141
August 18, 2026 0.0141
August 17, 2026 0.0141
August 14, 2026 0.0141
August 13, 2026 0.0141
August 12, 2026 0.0141
August 11, 2026 0.0141
August 10, 2026 0.0141
August 07, 2026 0.0141
August 06, 2026 0.0141
August 05, 2026 0.0141
August 04, 2026 0.0141
August 03, 2026 0.0141
July 31, 2026 0.0141
July 30, 2026 0.0141
July 29, 2026 0.0141
July 28, 2026 0.0141
July 27, 2026 0.0141
July 24, 2026 0.0141

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
InflaRx NV 1.517
BioNTech SE 1.199
Immatics NV 2.271
Arrowhead Pharmaceuticals, Inc. 19.46
Oncolytics Biotech, Inc. --

Price to Book Value Related Metrics

Price 0.10
Market Cap 1.474M